Compared with usual care, GLP-1 receptor agonists tirzepatide and semaglutide may be cost-effective options for patients with ...

Knee osteoarthritis (OA) is a prevalent chronic, progressive, degenerative condition in older individuals, characterized by ...

Tirzepatide offers more favorable return on investment, but greater benefits seen at lower costs for Roux-en-Y gastric bypass ...

Studies have found that it can improve gait and balance, reduce step length, and increase gait speed—all indicators of better ...

The global high tibial osteotomy plates market size was US$ 311.06 million in 2021. The global high tibial osteotomy plates market size is forecast to reach US$ 400.3 million by 2030, growing at a ...

Ohio is one of six states what will be testing a program using artificial intelligence to weed out inappropriate Medicare ...

Max Super Speciality Hospital, Saket, has set a global record in joint replacement surgery by discharging a patient just 18 ...

Elena Losina, PhD, codirector of the Orthopedics and Arthritis Center for Outcomes Research at Brigham and Women’s Hospital, discusses the cost-effectiveness of varying weight loss interventions.

NPPA extends ceiling price fixation on orthopaedic implants for two months: Our Bureau, New Delhi Thursday, September 18, ...

Objectives Night work disrupts sleep, which may increase inflammatory processes, pain sensitivity and pain perception. We ...

Details of a new drug that aims to treat the underlying causes of obesity are being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria ...

This was consistent with previous trial results of injectable Wegovy®.1,3 “The oral semaglutide 25 mg data show compelling ...